An atlas of active enhancers across human cell types and tissues
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers. We further explore the utility of enhancer redundancy, which explains gene expression strength rather than expression patterns. The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation. Using the FANTOM5 CAGE expression atlas, the authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify over 40,000 enhancer candidates from over 800 human cell and tissue samples across the whole human body. FANTOM5 (standing for functional annotation of the mammalian genome 5) is the fifth major stage of a major international collaboration that aims to dissect the transcriptional regulatory networks that define every human cell type. Two Articles in this issue of Nature present some of the project's latest results. The first paper uses the FANTOM5 panel of tissue and primary cell samples to define an atlas of active, in vivo bidirectionally transcribed enhancers across the human body. These authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify more than 40,000 enhancer candidates from over 800 human cell and tissue samples. The enhancer atlas is used to compare regulatory programs between different cell types and identify disease-associated regulatory SNPs, and will be a resource for studies on cell-type-specific enhancers. In the second paper, single-molecule sequencing is used to map human and mouse transcription start sites and their usage in a panel of distinct human and mouse primary cells, cell lines and tissues to produce the most comprehensive mammalian gene expression atlas to date. The data provide a plethora of insights into open reading frames and promoters across different cell types in addition to valuable annotation of mammalian cell-type-specific transcriptomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although enriched, histone modification and cofactor binding is not completely predictive of enhancer activity54,58,72,77,105.”
From Towards a comprehensive catalogue of validated and target-linked human enhancers (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The majority of active enhancers are themselves transcribed, producing enhancer RNAs (eRNAs) in a bi-directional manner [73–77].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of their sequence properties, enhancers and promoters tend to differ in GC content, with many promoters and only a subset of enhancers containing CpG islands [74, 249].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“We filtered intragenic CAGE TCs with GG-initiation and those overlapping with coding exons and annotated enhancers24,70”
From Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes (2023) · cites this paper as [24]
In the citing paper
“as regulatory elements are subject to positive selection pressure, we identified sequences showing the highest conservation across mammalian species, including humans25–29.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Cited by
Items 701–800 of 1,017
Laufer, B. I., Hwang, H., Ciernia, A. V., Mordaunt, C. E., & LaSalle, J. M. (2019) · Epigenetics · doi:10.1080/15592294.2019.1609867 · Cited by 49
“The hypermethylated DMRs were uniquely de-enriched for FANTOM5 permissive enhancers [26] and 3’ UTRs of genes (Figure 4(a)).”
BackgroundTranscriptionally active enhancers in human cancer cells
Lidschreiber, K., Jung, L. A., von der Emde, H., Dave, K., Taipale, J., Cramer, P., & Lidschreiber, M. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209873 · Cited by 51
Decoupling of evolutionary changes in transcription factor binding and gene expression in mammals
Wong, E. S., Thybert, D., Schmitt, B. M., Stefflova, K., Odom, D. T., & Flicek, P. (2015) · Genome Research · doi:10.1101/gr.177840.114 · Cited by 46
“Distal peaks were down-weighed as proximal enhancers are generallymore predictive of gene expression than distal ones (Andersson et al. 2014).”
BackgroundSLIC-CAGE: high-resolution transcription start site mapping using nanogram-levels of total RNA
Cvetešić, N., Leitch, H. G., Borkowska, M., Müller, F., Carninci, P., Hájková, P., & Lenhard, B. (2018) · Genome Research · doi:10.1101/gr.235937.118 · Cited by 49
“…TSS positions in the genome improves identification of core promoter sequences and led to the discovery of new core promoter and active enhancer sequences (Andersson et al. 2014; The FANTOM Consortium et al. 2014; Haberle et al. 2014; for review, see Lenhard et al. 2012; Haberle and Lenhard 2016).”
Self-citationGenomicKB: a knowledge graph for the human genome
Feng, F., Tang, F., Gao, Y., Zhu, D., Li, T., Yang, S., Yao, Y., Huang, Y., & Liu, J. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac957 · Cited by 60
“Correlate with”
Lee, S., Choi, J., Park, J., Hong, C. P., Choi, D., Han, S., Choi, K., Roh, T., Hwang, D., & Hwang, I. (2023) · Genome biology · doi:10.1186/s13059-023-02952-7 · Cited by 53
“Gene body regions often contain functional elements, such as enhancers [85, 86].”
BackgroundChen, C., Shi, W., Balaton, B. P., Matthews, A., Li, Y., Arenillas, D. J., Mathelier, A., Itoh, M., Kawaji, H., Lassmann, T., et al. (2016) · Scientific Reports · doi:10.1038/srep37324 · Cited by 48
Self-citationTrinh, L. A., Chong-Morrison, V., Gavriouchkina, D., Hochgreb, T., Senanayake, U., Fraser, S. E., & Sauka‐Spengler, T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.045 · Cited by 47
Dmitrijeva, M., Ossowski, S., Serrano, L., & Schaefer, M. H. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky498 · Cited by 76
“We considered separately the 6605 probes located in regions defined as Human Enhancers by the FANTOM5 Enhancer Atlas (62) because enhancers have previously been shown to be targeted by aberrant methylation in cancer in a manner different from other intergenic regions (63,64).”
BackgroundOh, G., Koncevičius, K., Ebrahimi, S., Carlucci, M., Groot, D. E., Nair, A., Zhang, A., Kriščiūnas, A., Oh, E. S., Labrie, V., et al. (2019) · Genome Biology · doi:10.1186/s13059-018-1608-9 · Cited by 46
Chen, Z., Wen, W., Beeghly-Fadiel, A. C., Shu, X., Díez‐Obrero, V., Long, J., Bao, J., Wang, J., Liu, Q., Cai, Q., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.07.006 · Cited by 47
“Recently, variants have been annotated in functional regions genome-wide through the use of various emerging functional genomic resources from the ENCODE,(24) Roadmap(25,26) and FANTOM5.(27) Potential functional variants can be examined by their locations in transcription factor motifs,(9,28,29) histone modifications,…”
BackgroundGarland, W., & Jensen, T. H. (2020) · WIREs RNA · doi:10.1002/wrna.1572 · Cited by 45
“…such RNA species may undergo inefficient or aberrant 30 end processing, producing unprotected 30 ends, that are obvious targets for 30–50 exonucleases, such as the nuclear exosome complex (Andersson et al., 2014; Y. Chen et al., 2016; Flynn, Almada, Zamudio, & Sharp, 2011; Preker et al., 2008).”
BackgroundSelf-citationGlobal Analysis of Enhancer Targets Reveals Convergent Enhancer-Driven Regulatory Modules
Xie, S., Armendariz, D., Zhou, P., Duan, J., & Hon, G. C. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.073 · Cited by 46
“Current efforts have focused largely on identifying the direct target genes of enhancers, using methods including computational correlation of epigenetic modifications (Andersson et al., 2014; Shen et al., 2012), three-dimensional chromatin looping (Fang et al.”
MethodResolving mechanisms of immune‐mediated disease in primary CD4 T cells
Bourges, C., Groff, A. F., Burren, O. S., Gerhardinger, C., Mattioli, K., Hutchinson, A., Hu, T. X., Anand, T., Epping, M. W., Wallace, C., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012112 · Cited by 52
The 3D Genome: From Structure to Function
Mohanta, T. K., Mishra, A. K., & Al‐Harrasi, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111585 · Cited by 53
“It has been well reported that enhancers are present at variable distances in highly expressed genes [188].”
BackgroundWalker, V. M., Zheng, J., Gaunt, T. R., & Smith, G. D. (2022) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-122120-024910 · Cited by 58
Transposable elements in plants: Recent advancements, tools and prospects
Ramakrishnan, M., Satish, L., Sharma, A., Vinod, K. K., Emamverdian, A., Zhou, M., & Wei, Q. (2022) · Plant Molecular Biology Reporter · doi:10.1007/s11105-022-01342-w · Cited by 55
Decoding enhancer complexity with machine learning and high-throughput discovery
Smith, G. D., Ching, W. H., Cornejo‐Páramo, P., & Wong, E. S. W. (2023) · Genome biology · doi:10.1186/s13059-023-02955-4 · Cited by 53
“…of nascent transcript [61, 62]. eRNAs are identified using assays that enrich for active 5’ TSSs, such as CAGE, or nascent transcript assays, such as PRO-seq and GRO-seq, where the expression level of transcripts is considered a functional quantification of enhancer activity [11, 61, 63, 64].”
BackgroundGenome instability: a conserved mechanism of ageing?
Vijg, J., Dong, X., Milholland, B., & Zhang, L. (2017) · Essays in Biochemistry · doi:10.1042/ebc20160082 · Cited by 45
“However, the number of active enhancers in a given cell type has been predicted to be well over 10,000 [62], reflecting the promiscuous character of transcription factors in enhancer utilization.”
BackgroundVersatile interactions and bioinformatics analysis of noncoding RNAs
Chen, Q., Meng, X., Liao, Q., & Chen, M. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bby050 · Cited by 46
Li, H., Qu, N., Hui, L., Cai, X. M., Zhang, C., Zhong, B., Zhang, S.-F., Chen, J., Xia, B., Wang, L., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0777-y · Cited by 46
Taylor, T., Sikorska, N., Shchuka, V. M., Chahar, S., Ji, C., Macpherson, N. N., Moorthy, S. D., de Kort, M. A. C., Mullany, S., Khader, N., et al. (2022) · Genes & Development · doi:10.1101/gad.349489.122 · Cited by 45
“Enhancers can regulate single or multiple genes (Andersson et al. 2014; Fukaya et al. 2016; Moorthy et al. 2017; Allahyar et al. 2018), and skip over adjacent genes to modulate specific targets from megabase-level distances (Lettice et al. 2003; Sanyal et al. 2012).”
Sirtuin 7 super-enhancer drives epigenomic reprogramming in hepatocarcinogenesis
Wu, F., Xu, L., Tu, Y., Cheung, O. K.-W., Szeto, L. L. M., Mok, M. T. S., Yang, W., Kang, W., Cao, Q., Lai, P. B. S., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.039 · Cited by 46
Integrative genomic analyses in adipocytes implicate DNA methylation in human obesity and diabetes
McAllan, L., Baranas̆ić, D., Villicaña, S., Brown, S., Zhang, W., Lehne, B. C., Adamo, M., Jenkinson, A. D., Elkalaawy, M., Mohammadi, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38439-z · Cited by 50
Long Non-Coding RNA Expression during Aging in the Human Subependymal Zone
Barry, G., Guennewig, B., Fung, S. J., Kaczorowski, D. C., & Weickert, C. S. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00045 · Cited by 45
“In a comprehensive study of enhancer regions, Andersson and colleagues designated this transcript as a possible actively transcribed enhancer (52).”
BackgroundGene activation by metazoan enhancers: Diverse mechanisms stimulate distinct steps of transcription
Beagrie, R. A., & Pombo, A. (2016) · BioEssays · doi:10.1002/bies.201600032 · Cited by 44
“Enhancers are now thought to be widespread in mammalian genomes; the human genome contains an estimated 50 thousand to 500 thousand enhancers in total [2, 3].”
BackgroundCremer, M., Schmid, V. J., Kraus, F., Markaki, Y., Hellmann, I., Maiser, A., Leonhardt, H., John, S., Stamatoyannopoulos, J. A., & Cremer, T. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0146-0 · Cited by 45
“We used the data sets of Human Other Regulatory Regions, which only identified FANTOM annotations [49] as well as Human Regulatory Features to find annotated regulatory elements and Human Regulatory Evidence to get a better idea, what kind of chromatin marks or binding sites were found [66].”
MethodCpG traffic lights are markers of regulatory regions in human genome
Lioznova, A. V., Khamis, A. M., Artemov, A. V., Besedina, E. G., Ramensky, V. E., Bajić, V. B., Kulakovskiy, I. V., & Medvedeva, Y. A. (2019) · BMC Genomics · doi:10.1186/s12864-018-5387-1 · Cited by 57
Computational Biology Solutions to Identify Enhancers-target Gene Pairs
Hariprakash, J. M., & Ferrari, F. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.06.012 · Cited by 49
“An earlier regression-based approach was adopted by the FANTOM project consortium as described in Andersson et al. [87].”
MethodZhou, H., Simion, V., Pierce, J. B., Haemmig, S., Chen, A. F., & Feinberg, M. W. (2020) · The FASEB Journal · doi:10.1096/fj.202001654rr · Cited by 51
Tao, H., Li, H., Xu, K., Hong, H., Jiang, S., Du, G., Wang, J., Sun, Y., Huang, X., Ding, Y., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa405 · Cited by 48
“Recent studies have shown that many noncoding single nucleotide polymorphisms (SNPs), identified in genome-wide association study (GWAS), are frequently located in cell linespecific enhancers and associated with risks of numerous common diseases [87, 88].”
BackgroundIndexing Effects of Copy Number Variation on Genes Involved in Developmental Delay
Uddin, M. J., Pellecchia, G., Thiruvahindrapuram, B., D’Abate, L., Merico, D., Chan, A. J. S., Zarrei, M., Tammimies, K., Walker, S., Gazzellone, M. J., et al. (2016) · Scientific Reports · doi:10.1038/srep28663 · Cited by 45
Pikkupeura, L. M., Bressan, R. B., Guiu, J., Chen, Y., Maimets, M., Mayer, D., Schweiger, P. J., Hansen, S. L., Maciag, G. J., Larsen, H. L., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf9460 · Cited by 50
Self-citationThe Consensus 5' Splice Site Motif Inhibits mRNA Nuclear Export
Lee, E. S., Akef, A., Mahadevan, K., & Palazzo, A. F. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122743 · Cited by 42
“Again, since splicing would naturally eliminate 5’SS motifs, we restricted ourselves to naturally intronless eRNAs as annotated by the FANTOM5 project [44].”
BackgroundMethodInfluentialPhenotypic variability in human skin mast cells
Babina, M., Guhl, S., Artuc, M., Trivedi, N. N., & Zuberbier, T. (2016) · Experimental Dermatology · doi:10.1111/exd.12924 · Cited by 46
Morrison, J., Laurie, C. C., Marazita, M. L., Sanders, A. E., Offenbacher, S., Salazar, C. R., Conomos, M. P., Thornton, T. A., Jain, D., Laurie, C. A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv506 · Cited by 53
“Of note, datafrom large-scale effortsto identify functional non-coding elements [ENCODE (19), Roadmap Epigenomics (20) and FANTOM5 (21) projects] show that three SNPs (rs6947923, rs73409446 and rs73411544) in high-linkage disequilibrium ( r 2 ≥ 0.7) with rs190395159 occur within putative enhancers upstream of NAMPT (F…”
BackgroundInfluentialThe Determinants of Directionality in Transcriptional Initiation
Bagchi, D. N., & Iyer, V. R. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.03.005 · Cited by 51
Epigenetic memory: A macrophage perspective
Logie, C., & Stunnenberg, H. G. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.06.003 · Cited by 50
“‘enhancers’ modulate the activity of the promoters [12,13].”
Chattopadhyay, I., Wang, J., Qin, M., Gao, L., Holtz, R., Vessella, R. L., Leach, R. W., & Gelman, I. H. (2016) · Oncotarget · doi:10.18632/oncotarget.14401 · Cited by 43
“The finding that TOP2B only associates with the CDX2 site, which also has been identified as an eRNA-encoding enhancer [88], suggests that Src also modifies TOP2B.”
BackgroundResultProperties of STAT1 and IRF1 enhancers and the influence of SNPs
Hassan, M. A. E., Huang, K., Eswara, M. B. K., Xu, Z., Tao, Y., Aubry, A., Ni, Z., Livne-Bar, I., Sangwan, M., Ahmad, M. S., et al. (2017) · BMC Molecular Biology · doi:10.1186/s12867-017-0084-1 · Cited by 50
“Over 90% of the disease markers identified in GWAS studies lie within the non-protein-coding regions of the genome [48].”
BackgroundPian, L., Wen, X., Kang, L., Li, Z., Nie, Y., Du, Z., Yu, D., Zhou, L., Jia, L., Chen, J., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.013 · Cited by 51
“Additionally, many enhancer DNA elements can encode unpolyadenylated enhancer RNAs (eRNAs) that tightly regulate neighboring coding genes.(45,46) However, these eRNAs function primarily as activators rather than repressors when targeting promoters.”
BackgroundEnhancer RNAs: a missing regulatory layer in gene transcription
Mao, R., Wu, Y., Ming, Y., Xu, Y., Wang, S., Chen, X., Wang, X., & Fan, Y. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9370-9 · Cited by 47
Integrated epigenomic profiling reveals endogenous retrovirus reactivation in renal cell carcinoma
Siebenthall, K. T., Miller, C. P., Vierstra, J. D., Mathieu, J., Tretiakova, M., Reynolds, A. P., Sandstrom, R. S., Rynes, E., Neph, S. J., Haugen, E., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.063 · Cited by 45
“In 786-O cells, this DHS demarcated H3K36me3 signal, a mark associated with transcription elongation, the other end of which extended into annotated POU5F1 transcripts [41,42].”
BackgroundProgress, Challenges, and Surprises in Annotating the Human Genome
Zerbino, D. R., Frankish, A., & Flicek, P. (2020) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-121119-083418 · Cited by 50
“For this reason, currently available genome-wide annotations (6, 173).”
BackgroundEvaluating the informativeness of deep learning annotations for human complex diseases
Dey, K. K., van de Geijn, B., Kim, S. S., Hormozdiari, F., Kelley, D. R., & Price, A. L. (2020) · Nature Communications · doi:10.1038/s41467-020-18515-4 · Cited by 52
Tausendschön, M., Rehli, M., Dehne, N., Schmidl, C., Döring, C., Hansmann, M.-L., & Brüne, B. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.10.006 · Cited by 43
Self-citationSarda, S., Das, A., Vinson, C., & Hannenhalli, S. (2017) · Genome Research · doi:10.1101/gr.212050.116 · Cited by 43
Guiblet, W. M., DeGiorgio, M., Cheng, X., Chiaromonte, F., Eckert, K. A., Huang, Y.-F., & Makova, K. D. (2021) · Genome Research · doi:10.1101/gr.269589.120 · Cited by 46
“Although we originally analyzed FANTOM enhancers (Andersson et al. 2014; FANTOM Consortium and the RIKEN PMI and CLST (DGT) 2014; Lizio et al. 2015), analyzing ENCODE enhancers (The ENCODE Project Consortium et al. 2020) led to a similar HKA odds ratio (odds ratio = 1.23, P< 3.5 × 10−15)…”
BackgroundMethodInfluentialPrioritizing effector genes at trait-associated loci using multimodal evidence
Schipper, M., de Leeuw, C., Maciel, B. D. A. P. C., Wightman, D. P., Hubers, N., Boomsma, D. I., O’Donovan, M. C., & Posthuma, D. (2025) · Nature Genetics · doi:10.1038/s41588-025-02084-7 · Cited by 64
Functional dissection of complex trait variants at single-nucleotide resolution
Siraj, L., Castro, R. I., Dewey, H. B., Kales, S., Butts, J. C., Nguyen, T. T. L., Kanai, M., Berenzy, D., Mouri, K., Wang, Q. S., et al. (2026) · Nature · doi:10.1038/s41586-026-10121-6 · Cited by 61
Approaches for establishing the function of regulatory genetic variants involved in disease
Knight, J. C. (2014) · Genome Medicine · doi:10.1186/s13073-014-0092-4 · Cited by 42
“The FANTOM5 project (for ‘functional annotation of the mammalian genome 5’) has recently published work complementing and extending ENCODE by using cap analysis of gene expression (CAGE) and single-molecule sequencing to define comprehensive atlases of transcripts, transcription factors, promoters, enhancers and trans…”
BackgroundMethodInfluentialLarson, N. B., McDonnell, S. K., French, A. J., Fogarty, Z. C., Cheville, J. C., Middha, S., Riska, S. M., Baheti, S., Nair, A., Wang, L., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.04.015 · Cited by 50
Song, B., Morse, D., Song, Y., Fu, Y., Lin, X., Wang, W., Cheng, S., Chen, W., Liu, X., & Lin, S. (2017) · Genome Biology and Evolution · doi:10.1093/gbe/evx144 · Cited by 45
Genome-wide Identification and Characterization of Enhancers Across 10 Human Tissues
Xiong, L., Kang, R., Ding, R., Kang, W., Zhang, Y., Liu, W., Huang, Q., Meng, J., & Guo, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.26605 · Cited by 55
“(CAGE) at the 5′ end of transcripts [15].”
BackgroundMethodInfluentialControl of p53-dependent transcription and enhancer activity by the p53 family member p63
Uzunbas, G. K., Ahmed, F., & Sammons, M. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007965 · Cited by 42
“In vivo, p63 is required for lineage commitment and self-renewal of basal epithelial cells (38), and p53 family motifs are highly and specifically enriched in epithelium-specific enhancers (37).”
BackgroundResultC-Jun drives melanoma progression in PTEN wild type melanoma cells
Kappelmann‐Fenzl, M., Gebhard, C., Matthies, A. O., Kuphal, S., Rehli, M., & Bosserhoff, A. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1821-9 · Cited by 49
Self-citationEnhancer–gene maps in the human and zebrafish genomes using evolutionary linkage conservation
Clément, Y., Torbey, P., Gilardi-Hebenstreit, P., & Crollius, H. R. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1199 · Cited by 41
Pośpiech, E., Kukla‐Bartoszek, M., Karłowska-Pik, J., Zieliński, P., Woźniak, A., Boroń, M., Dąbrowski, M., Zubańska, M., Jarosz, A., Grzybowski, T., et al. (2020) · BMC Genomics · doi:10.1186/s12864-020-06926-y · Cited by 44
Bejjani, F., Tolza, C., Boulanger, M., Downes, D. J., Romero, R., Maqbool, M. A., Aabidine, A. Z. E., Andrau, J., Lèbre, S., Bréhélin, L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab053 · Cited by 47
Fish, A. E., Chen, L., & Capra, J. A. (2017) · Genome Biology and Evolution · doi:10.1093/gbe/evx194 · Cited by 44
Schmidt, A. F., Bourfiss, M., Alasiri, A., Anton, E. P., Chopade, S., van Vugt, M., van der Laan, S. W., Groß, C., Clarkson, C., Henry, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.add4984 · Cited by 47
“…by exploring their tissue-specific mRNA expression from the HPA ( 23 ), sourcing the consensus expression obtained by normalizing TPM (transcripts per million) values from three independent transcriptomics datasets: GTEx ( 53 ), Fantom5 ( 54 ), and HPA ’ s own RNA sequencing experiments ( 23 ).”
Bittner, N., Shi, C., Zhao, D., Ding, J., Southam, L., Swift, D., Kreitmaier, P., Tutino, M., Stergiou, O. S., Cheung, J. T. S., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224945 · Cited by 47
“When checking for expression of enhancer RNA in the FANTOM5 database, 53 we could not find any enhancer transcripts matching these regions.”
Yoshiji, S., Lu, T., Butler‐Laporte, G., Carrasco-Zanini, J., Su, C., Chen, Y., Liang, K., Willett, J., Wang, S., Adra, D., et al. (2023) · Nature Genetics · doi:10.1016/j.cjca.2023.06.321 · Cited by 65
Self-citationDavis, M. R., Arner, E., Duffy, C. R. E., Sousa, P. A. D., Dahlman, I. A., Arner, P., & SUMMERS, K. M. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.06.009 · Cited by 47
“The remaining promoters showed very low activity, except for p13@FBN1 which exhibited roughly balanced bilateral expression in all three replicates in the first 24 hours (Figure 3D), suggesting that it may have enhancer activity in this system [51].”
Self-citationPrioritization and functional assessment of noncoding variants associated with complex diseases
Zhou, L., & Zhao, F. (2018) · Genome Medicine · doi:10.1186/s13073-018-0565-y · Cited by 39
“, ENCODE [7] and FANTOM5 [8]) and human genome resequencing projects (e.”
BackgroundNon-coding RNAs underlie genetic predisposition to breast cancer
Marjaneh, M. M., Beesley, J. M., O’Mara, T. A., Mukhopadhyay, P., Koufariotis, L. T., Kazakoff, S. H., Hussein, N., Fachal, L., Bartoniček, N., Hillman, K. M., et al. (2020) · Genome biology · doi:10.1186/s13059-019-1876-z · Cited by 49
“Several studies have shown that most genetic variants identified through GWAS are non-coding and enriched in cell type-specific enhancers relevant to the GWAS trait [9, 16].”
BackgroundGažová, I., Lefèvre, L., Bush, S. J., Clohisey, S., Arner, E., de Hoon, M., Severin, J., van Duin, L., Andersson, R., Lengeling, A., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00498 · Cited by 49
“1353 of the less stringent set and 656 of the more stringent set were found in the full set of ∼63,000 enhancers (Andersson et al., 2014), indicating that this analysis has discovered some potential novel enhancers.”
BackgroundMethodInfluentialSelf-citationJing, F., Zhang, S., & Zhang, S. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03844-4 · Cited by 40
Ciuculete, D. M., Boström, A. E., Voisin, S., Philipps, H., Titova, O. E., Bandstein, M., Nikontovic, L., Williams, M. J., Mwinyi, J., & Schiöth, H. B. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.275 · Cited by 40
TermGenie – a web-application for pattern-based ontology class generation
Dietze, H., Berardini, T., Foulger, R. E., Hill, D. P., Lomax, J., Osumi-Sutherland, D., Roncaglia, P., & Mungall, C. (2014) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-5-48 · Cited by 39
“…the CL is to rigorously describe samples collected as part of large next-generation sequencing projects such as Functional Annotation of Mammalian Genomes 5 (FANTOM5) and the Encyclopaedia of DNA Elements (ENCODE), allowing analyses that yield insight into properties of different cell types [29].”
BackgroundSelf-citationEpigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone
Enuka, Y., Feldman, M. E., Chowdhury, A., Srivastava, S., Lindzen, M., Sas‐Chen, A., Massart, R., Cheishvili, D., Suderman, M. J., Zaltsman, Y., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx865 · Cited by 40
“Next, we used the FANTOM5 enhancer atlas (43) to associate enhancer regions to specific genes.”
MethodPepsin properties, structure, and its accurate measurement: a narrative review
Stanforth, K. J., Wilcox, M. D., Chater, P. I., Brownlee, I. A., Zakhour, M. I., Banecki, K. M. R. M., & Pearson, J. P. (2021) · Annals of Esophagus · doi:10.21037/aoe-20-95 · Cited by 40
“This can be dismissed as the Human Expression Atlas lists nine studies on tissue expression of pepsinogen and only one reports any in the tongue at levels too low to account for the levels detected in saliva (64).”
BackgroundeRNAbase: a comprehensive database for decoding the regulatory eRNAs in human and mouse
Song, C., Zhang, G., Mu, X., Feng, C., Zhang, Q., Song, S., Zhang, Y., Yin, M., Zhang, H., Tang, H., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad925 · Cited by 41
“HACER, PINTS and FANTOM5 provide a list of human eRNAs from these genome-wide RNA-seq assays, such as CAGE and GR O / PR O-seq ( 20 ,21 ).”
MethodTranscriptional enhancers: functional insights and role in human disease
Miguel-Escalada, I., Pasquali, L., & Ferrer, J. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.08.009 · Cited by 40
“All such features can now be studied with high-throughput sequencing-based assays, which has enabled the generation of enhancer maps in numerous cell lines and primary tissues [8,9 ,10,11].”
BackgroundSelf-citationNovel regional age-associated DNA methylation changes within human common disease-associated loci
Bell, C. G., Xia, Y., Yuan, W., Gao, F., Ward, K. J., Roos, L., Mangino, M., Hysi, P. G., Bell, J. T., Wang, J., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1051-8 · Cited by 48
“Repeats All, SINE, LINE, LTR repeats, FANTOM5 Enhancers [36], Dynamic”
BackgroundMethodInfluentialSimpson, E. M., Korecki, A. J., Fornés, O., McGill, T. J., Vargas, J. L. C., Agostinone, J., Farkas, R. A., Hickmott, J. W., Lam, S. L., Mathelier, A., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.118 · Cited by 43
“…integration of multiple sources of evidence: transcribed promoter and enhancer regions (iden-tified through cap analysis of gene expression [CAGE] 26,27 and genomic run-on sequence [GRO-seq] data 28 ), predicted promoter and enhancer regions (ChromHMM and Segway 29,30 ), chromatin accessibility…”
Chu, T., Wang, Z., Chou, S., & Danko, C. G. (2018) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.70 · Cited by 48
Morioka, M. S., Kawaji, H., Nishiyori-Sueki, H., Murata, M., Kojima-Ishiyama, M., Carninci, P., & Itoh, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0327-7_20 · Cited by 50
Self-citationMitochondrial stress and GDF15 in the pathophysiology of sepsis
Fujita, Y., Ito, M., & Ohsawa, I. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108668 · Cited by 42
Coignard, J., Lush, M. J., Beesley, J., O’Mara, T. A., Dennis, J., Tyrer, J. P., Barnes, D. R., McGuffog, L., Leslie, G., Bolla, M. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20496-3 · Cited by 49
Genomic and functional conservation of lncRNAs: lessons from flies
Camilleri‐Robles, C., Amador, R., Klein, C. C., Guigó, R., Corominas, M., & Ruiz‐Romero, M. (2022) · Mammalian Genome · doi:10.1007/s00335-021-09939-4 · Cited by 53
“Transcription has been observed from multiple active enhancers in mammals (Andersson et al. 2014; Arner et al. 2015; De Santa et al. 2010; Kim et al. 2010), Drosophila (Henriques et al. 2018; Meers et al. 2018) and Caenorhabditis elegans (Chen et al. 2013).”
BackgroundComparative transcriptomics of primary cells in vertebrates
Alam, T., Agrawal, S., Severin, J., Young, R. S., Andersson, R., Arner, E., Hasegawa, A., Lizio, M., Ramilowski, J. A., Abugessaisa, I., et al. (2020) · Genome Research · doi:10.1101/gr.255679.119 · Cited by 46
“Genome Research 955 (Andersson et al. 2014) allows changes in their regulatory connections in specific conditions while avoiding pleiotropic deleterious effects on the organism in general (Carroll 2008).”
BackgroundSelf-citationNepal, C., & Andersen, J. B. (2023) · Nature Communications · doi:10.1038/s41467-023-38272-4 · Cited by 39
Yang, M., Lee, J. H., Zhang, Z., de la Rosa, R., Bi, M., Tan, Y., Liao, Y., Hong, J., Du, B., Wu, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107803 · Cited by 42
“Currently, functions of eRNAs have been mostly centered on the gene activation program (Andersson et al., 2014; Danko et al., 2015).”
Cooper, S., Parke, H. G., & Friedman, A. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126385 · Cited by 46
“When such analysis was conducted for the CEBPA locus in human neutrophils or monocytes, eight such putative enhancers were identified [30].”
MethodNarasimhan, K., Pillay, S., Huang, Y.-H., Jayabal, S., Udayasuryan, B., Veerapandian, V., Kolatkar, P., Cojocaru, V., Pervushin, K., & Jauch, R. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1390 · Cited by 39
“The location of cis-regulatory ‘enhancer’ DNA sequences that govern cellular identities is now known in many cell types and lists of transcription factors (TFs) that bind such enhancers and associated epigenetic signatures are expanding rapidly (1,2).”
BackgroundEnhancer-associated RNAs as therapeutic targets
Léveillé, N., Melo, C. A., & Agami, R. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1029452 · Cited by 40
“Recently, the FANTOM5 project created an atlas of active transcribed enhancers in a variety of mammalian primary cell types, cancer cell lines, and tissues [36].”
Backgroundp38 MAPK /MK2-mediated phosphorylation of RBM7 regulates the human nuclear exosome targeting complex
Tiedje, C., Lubas, M., Tehrani, M., Menon, M., Ronkina, N., Rousseau, S., Cohen, P., Kotlyarov, A., & Gaestel, M. (2014) · RNA · doi:10.1261/rna.048090.114 · Cited by 41
“Evidence demonstrates a role of the nuclear exosome and NEXT complexes in the decay of long noncoding RNA (lncRNAs), such as promoter-upstream transcripts (PROMPTs), enhancer RNAs (eRNAs), and extended U snRNAs (Preker et al. 2008; Lubas et al. 2011; Andersen et al. 2013; Andersson et al. 2014).”
Dynamics of chromatin accessibility and epigenetic state in response to UV damage
Schick, S., Fournier, D., Thakurela, S., Sahu, S. K., Garding, A., & Tiwari, V. K. (2015) · Journal of Cell Science · doi:10.1242/jcs.173633 · Cited by 39
“This goes along with previous suggestions that enhancer-nearest gene pairing only holds true for ∼40% of genes (Andersson et al., 2014; Doyle et al., 2014; Samee and Sinha, 2014).”
BackgroundEmerging themes in neuronal activity-dependent gene expression
Madabhushi, R., & Kim, T.-K. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.11.009 · Cited by 43
Yang, X. H., Nadadur, R. D., Hilvering, C. R. E., Bianchi, V., Werner, M. S., Mazurek, S. R., Gadek, M., Shen, K. M., Goldman, J. A., Tyan, L., et al. (2017) · eLife · doi:10.7554/elife.31683 · Cited by 42
“We further hypothesized that the intersection between Tbx5-dependent ncRNAs and regions of open chromatin, a global feature of enhancers (Andersson et al., 2014), would mark Tbx5-dependent enhancers.”
BackgroundO’Brien, T., Jia, P., Caporaso, N. E., Landi, M. T., & Zhao, Z. (2018) · Genome Medicine · doi:10.1186/s13073-018-0522-9 · Cited by 41
“We used this permissive set of enhancers and their corresponding transcribed target genes from the Promoter Enhancer Slider Selector Tool (PrESSTo) website [58, 60].”
MethodA Guide for Designing and Analyzing RNA-Seq Data
Chatterjee, A., Ahn, A., Rodger, E. J., Stockwell, P. A., & Eccles, M. R. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7834-2_3 · Cited by 49
Nuclear compartmentalization, dynamics, and function of regulatory DNA sequences
Cremer, M., & Cremer, T. J. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22714 · Cited by 42
“”(1,15,17,18) With up to 10(6) sites enhancers represent the most abundant group of TREs.(19) After recruitment of binding factors, enhancers presumably act by juxtaposition to a promoter (Figure 1B).”
BackgroundInfluentialBush, S. J., Freem, L. J., MacCallum, A. J., O’Dell, J., Wu, C., Afrasiabi, C., Psifidi, A., Stevens, M. P., Smith, J., SUMMERS, K. M., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4972-7 · Cited by 51
Self-citationThieffry, A., López‐Márquez, D., Bornholdt, J., Malekroudi, M. G., Bressendorff, S., Barghetti, A., Sandelin, A., & Brodersen, P. (2022) · The Plant Cell · doi:10.1093/plcell/koac108 · Cited by 41
“This is because of recent findings that enhancers in animal cells 95 can be identified as DNAse Hypersensitive Sites (DHSs) that produce so-called enhancer 96 RNAs (eRNAs): Bidirectional, short-lived transcripts, best observed upon inactivation of the 97 RNA exosome complex (Andersson et al. 2014; Andersson and Sandel…”
BackgroundSelf-citationEnhancer RNAs step forward: new insights into enhancer function
Harrison, L. J., & Bose, D. A. (2022) · Development · doi:10.1242/dev.200398 · Cited by 42
Jiang, Y., Harigaya, Y., Zhang, Z., Zhang, H., Zang, C., & Zhang, N. R. (2022) · Cell Systems · doi:10.1016/j.cels.2022.08.004 · Cited by 44
Splicing of enhancer-associated lincRNAs contributes to enhancer activity
Tan, J. Y., Biasini, A., Young, R. S., & Marques, A. C. (2020) · Life Science Alliance · doi:10.26508/lsa.202000663 · Cited by 47
“We further propose that some enhancers associated with eRNA transcription (Andersson et al, 2014), which generally turn over rapidly during mammalian evolution (Villar et al, 2015), have evolved molecular features, including splicing that strengthened their transcription and led to increased…”
Simple and efficient profiling of transcription initiation and transcript levels with STRIPE-seq
Policastro, R. A., Raborn, R. T., Brendel, V., & Zentner, G. E. (2020) · Genome Research · doi:10.1101/gr.261545.120 · Cited by 45
“…CAGE has been extensively used to characterize the landscape of transcription initiation across numerous species (Valen et al. 2009; Hoskins et al. 2011; Nepal et al. 2013; Andersson et al. 2014; The FANTOM Consortium and the RIKEN PMI and CLST (DGT) 2014; Lizio et al. 2017; Kurihara et al. 2018).”
Background
Metadata
- Authors
- The FANTOM Consortium, Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., Ntini, E., Arner, E., Valen, E., Li, K., Schwarzfischer, L., Glatz, D., Raithel, J., Lilje, B., Rapin, N., Bagger, F. O., Jørgensen, M., Andersen, P. R., Bertin, N., Rackham, O., Burroughs, A. M., Baillie, J. K., Ishizu, Y., Shimizu, Y., Furuhata, E., Maeda, S., Negishi, Y., Mungall, C. J., Meehan, T. F., Lassmann, T., Itoh, M., Kawaji, H., Kondo, N., Kawai, J., Lennartsson, A., Daub, C. O., Heutink, P., Hume, D. A., Jensen, T. H., Suzuki, H., Hayashizaki, Y., Müller, F., Forrest, A. R. R., Carninci, P., Rehli, M., & Sandelin, A.
- Affiliations
- University of Copenhagen (DK)
- University Hospital Regensburg (DE)
- University of Birmingham (GB)
- University of North Carolina at Chapel Hill (US)
- RIKEN (JP)
- Aarhus University (DK)
- Roslin Institute (GB)
- European Bioinformatics Institute (GB)
- Karolinska Institutet (SE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- ORCID
- Andersson, Robin
- Gebhard, Claudia
- Miguel-Escalada, Irene
- Hoof, Ilka
- Bornholdt, Jette
- Chen, Yun
- Schmidl, Christian
- Suzuki, Takahiro
- Ntini, Evgenia
- Valen, Eivind
- Li, Kang
- Lilje, Berit
- Rapin, Nicolas
- Bagger, Frederik Otzen
- Andersen, Peter Refsing
- Bertin, Nicolas
- Rackham, Owen
- Burroughs, A. Maxwell
- Baillie, J. Kenneth
- Ishizu, Yuri
- Shimizu, Yuri
- Furuhata, Erina
- Meehan, Terrence F.
- Lassmann, Timo
- Itoh, Masayoshi
- Kawaji, Hideya
- Kawai, Jun
- Lennartsson, Andreas
- Daub, Carsten O.
- Heutink, Peter
- Hume, David A.
- Jensen, Torben Heick
- Suzuki, Harukazu
- Hayashizaki, Yoshihide
- Müller, Ferenc
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- Venue
- Nature
- Published
- 2014-03
- Volume
- 507
- Issue
- 7493
- Pages
- 455-461
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5215096
- OpenAlex
- W2015845481
- Cited by
- 2,550
- References
- 81
- Citations by year
- 2026: 93 · 2025: 140 · 2024: 207 · 2023: 185 · 2022: 225 · 2021: 280 · 2020: 232 · 2019: 226 · 2018: 261 · 2017: 208 · 2016: 186 · 2015: 212 · 2014: 89
- FWCI
- 95.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- PubMed Central (acceptedVersion)
- SDL (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Wellcome Trust (103258/Z/13/Z)
- European Commission (FP7/2007–2013/ERC, 2007–2013, FP7 2007-2013, FP7/2007)
- Deutsche Forschungsgemeinschaft (FP7/2007–2013)
- Ministry of Education, Culture, Sports, Science and Technology
- Lundbeckfonden (R167-2013-15058, R82-2010-6779)
- Novo Nordisk
- Novo Nordisk Fonden (NNF12OC0001211)
- H. Lundbeck A/S
- Biotechnology and Biological Sciences Research Council (BBS/E/D/20251969, BB/I024801/1)
- Japan Society for the Promotion of Science (24659373, 25330333, 22228005)
- RIKEN
- National Institute of Dental and Craniofacial Research (R01DE022969)
- FP7 Ideas: European Research Council (204135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- enhancers, bidirectional transcription, unspliced RNA, FANTOM5, CAGE, cell type-specific gene regulation, regulatory single nucleotide polymorphisms, enhancer redundancy, transcription start sites, promoter usage, human cell types, tissue-specific enhancers
- MeSH terms
- Atlases as Topic, Cell Line, Cells, Cultured, Enhancer Elements, Genetic, Gene Expression Regulation, HeLa Cells, Humans, Organ Specificity, Promoter Regions, Genetic, RNA, Messenger, Cluster Analysis, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Transcription Initiation Site, Molecular Sequence Annotation, Transcription Initiation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.